120 related articles for article (PubMed ID: 20595686)
1. The role of SATB1 in breast cancer pathogenesis.
Iorns E; Hnatyszyn HJ; Seo P; Clarke J; Ward T; Lippman M
J Natl Cancer Inst; 2010 Aug; 102(16):1284-96. PubMed ID: 20595686
[TBL] [Abstract][Full Text] [Related]
2. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
3. SATB1 gene expression and breast cancer prognosis.
Hanker LC; Karn T; Mavrova-Risteska L; Ruckhäberle E; Gaetje R; Holtrich U; Kaufmann M; Rody A; Wiegratz I
Breast; 2011 Aug; 20(4):309-13. PubMed ID: 20980149
[TBL] [Abstract][Full Text] [Related]
4. A new path to the cancer epigenome.
Richon VM
Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
[No Abstract] [Full Text] [Related]
5. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo.
Pavan Kumar P; Purbey PK; Sinha CK; Notani D; Limaye A; Jayani RS; Galande S
Mol Cell; 2006 Apr; 22(2):231-43. PubMed ID: 16630892
[TBL] [Abstract][Full Text] [Related]
6. SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron.
Li K; Cai R; Dai BB; Zhang XQ; Wang HJ; Ge SF; Xu WR; Lu J
Biochem Biophys Res Commun; 2007 Apr; 356(1):6-12. PubMed ID: 17343824
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
8. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
10. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract][Full Text] [Related]
12. FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.
McInnes N; Sadlon TJ; Brown CY; Pederson S; Beyer M; Schultze JL; McColl S; Goodall GJ; Barry SC
Oncogene; 2012 Feb; 31(8):1045-54. PubMed ID: 21743493
[TBL] [Abstract][Full Text] [Related]
13. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
[TBL] [Abstract][Full Text] [Related]
14. Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors.
Alaoui-Jamali MA; Song DJ; Benlimame N; Yen L; Deng X; Hernandez-Perez M; Wang T
Cancer Res; 2003 Jul; 63(13):3764-74. PubMed ID: 12839972
[TBL] [Abstract][Full Text] [Related]
15. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
[TBL] [Abstract][Full Text] [Related]
16. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
[TBL] [Abstract][Full Text] [Related]
20. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
